TFX - Teleflex Incorporated Stock Analysis

Teleflex Incorporated (TFX) is a publicly traded company listed on the NYSE. It operates in the Medical Instruments & Supplies industry, part of the broader Healthcare sector. The company has a market capitalization of 4.55B, generates annual revenue of 3.19B, and reports net income of -327.97M. As of the latest data, the stock is trading at 103.00 USD.

From a valuation and risk perspective, the stock presents the following profile: The P/E ratio is unavailable or not meaningful at this time. The PEG ratio is within a normal range, suggesting the stock is fairly priced for its expected growth. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The dividend yield (1.31%) is modest, often associated with growth-oriented companies. The stock has average market volatility, aligning with general market movement.

Analyst recommendation stands at Sell (2.71), indicating current market sentiment. Institutional ownership is reported at 106.24%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -41.66%, trading within a 52-week range of 102.58 - 185.94.

TFX - Teleflex Incorporated

103.00
Analyst Consensus
Sell 2.71
TFX – Analyst Rating Summary
Analyst Pie Chart
  • Strong Buy: 0
  • Buy: 1
  • Hold: 14
  • Sell: 5
  • Strong Sell: 1
  • Total Analysts:  21

Last update: 2026-01-20 04:46:56
Index: - P/E: - EPS (ttm): -7.36 Insider Own: 0.75% Shs Outstand: 44.19M Perf Week: -8.70%
Market Cap: 4.55B Forward P/E: 6.82 EPS next Y: 15.11 Insider Trans: 1.69% Shs Float: 43.85M Perf Month: -17.51%
Income(ttm): -327.97M PEG: 1.19 EPS next Q: 3.79 Inst Own: 106.24% Short Float: 3.97% Perf Quarter: -16.86%
Revenue(ttm): 3.19B P/S: 1.43 EPS this Y: 0.31% Inst Trans: -1.39% Short Ratio: 2.38 Perf Half Y: -7.26%
Book/sh: 86.48 P/B: 1.19 EPS next Y: 7.54% ROA: -4.27% Short Interest: 1.74M Perf Year: -41.66%
Cash/sh: 8.34 P/C: 12.35 EPS next 5Y: 5.75% ROE: -7.90% 52W Range: 102.58 - 185.94 Perf YTD: -15.60%
Dividend Est.: 1.35 (1.31%) P/FCF: 17.22 EPS past 3/5Y: -47.52% -31.49% ROIC: -5.05% 52W High: 185.94 -44.61% Beta: 0.91
Dividend TTM: 1.36 (1.32%) Quick Ratio: 1.53 Sales past 3/5Y: 2.74% 3.26% Gross Margin: 53.86% 52W Low: 102.58 0.41% Perf 5Y: -74.50%
Dividend Ex-Date: Nov 14, 2025 Current Ratio: 2.57 EPS Y/Y TTM: -245.18% Oper. Margin: 17.79% RSI (14): 30.43 Volatility: 3.38% 2.93%
Employees: 14100 Debt/Eq: 0.72 Sales Y/Y TTM: 5.43% Profit Margin: -10.28% Recom: 3.00 Target Price: 131.75
Option/Short: Yes / Yes LT Debt/Eq: 0.70 EPS Q/Q: -491.46% Payout: 91.92% Rel Volume: 1.12 Prev Close: 104.61
Sales Surprise: 0.01% EPS Surprise: 7.63% Sales Q/Q: 19.45% Earnings: Nov 06 BMO Avg Volume: 731.89K Price: 103.00
SMA20: -12.30% SMA50: -11.65% SMA200: -15.71% Undervalued: 27.91%
Volume: 819,217 Change: -1.54%
Graham's revised valuation formula
Discounted cash flow (DCF) model
Margin of safety

About Teleflex Incorporated

Teleflex, Inc. engages in the provision of medical technology products. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia, and Original Equipment Manufacturer and Development Services (OEM). The Americas, EMEA, and Asia segments are involved in the design, manufacture, and distribution of medical devices primarily used in critical care and surgical applications and generally serve two end-markets: hospitals and healthcare providers, and home health. The OEM segment refers to the design, manufacture, and supply of devices and instruments for other medical device manufacturers. The company was founded in 1943 and is headquartered in Wayne, PA.

Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.

Copyright © 2024 - 2026 www.stocks-expert.com All Rights Reserved.